BCL2 and prostate cancer: The POU1F1-derived tumors have 499 exclusive proteins that participate in events such as Platinum drug resistance (AKT3, BCL2 and GSTT2) and Prostate cancer (FGFR1, IGF1R and PDGFD) among others.